Candel’s R&D Day will include presentations and panel discussions from its executive leadership, clinical investigators, scientific advisors, and key collaborators. The event will provide an extensive ...

In an open letter to the Health Secretary, we hear from readers who are calling for targeted prostate cancer screening for men at high risk ...

Grey's Anatomy star James Pickens Jr. shared that he was recently diagnosed with prostate cancer, while his character on the ...

Zydus Lifesciences has secured USFDA approval for its Leuprolide Acetate injection, a treatment for advanced prostatic cancer.

This approval allows Zydus Lifesciences to enter the promising US market, where Leuprolide Acetate injection generates $69 ...

Study finds GLP-1 drugs may reduce risk of more than a dozen cancers, offering hope in Louisiana where obesity-related cancer ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation ...

A groundbreaking study reveals that combining two drugs significantly boosts survival for men with high-risk, recurring ...

In the US terminal market, Camcevi sales reached 2,399 units in October, up from 1,686 in September. This contributed to ...